Encouraging specific biomarkers-based therapeutic strategies for hepatocellular carcinoma.

Yao, Min; Yang, Jun-Ling; Wang, De-Feng; Wang, Li; Chen, Ying; Yao, Deng-Fu

Yao, Min; Yang, Jun-Ling; Wang, De-Feng; Wang, Li; Chen, Ying; Yao, Deng-Fu.

Afiliação

Yao M; Research Center of Clinical Medicine & Department of Immunology, Medical School of Nantong University, Nantong 226001, Jiangsu Province, China.
Yang JL; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
Wang DF; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
Wang L; Department of Medical Informatics, Medical School of Nantong University, Nantong 226001, Jiangsu Province, China.
Chen Y; Department of Oncology, Affiliated Second Hospital of Nantong University, Nantong 226001, Jiangsu Province, China.
Yao DF; Research Center of Clinical Medicine, Affiliated Hospital of Nantong University, Nantong 226001, Jiangsu Province, China. yaodf@ahnmc.com.

World J Clin Cases ; 10(11): 3321-3333, 2022 Apr 16.

Article em En | MEDLINE | ID: mdl-35611205

Palavras-chave

Carcinoembryonic proteins; Hepatocellular carcinoma; Immunotherapy; Signal molecules; Specific biomarkers; Wnt/ß-catenin pathway

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Tipo de estudo: Prognostic_studies Idioma: En Revista: World J Clin Cases Ano de publicação: 2022 Tipo de documento: Article País de afiliação: China País de publicação: Estados Unidos

Texto completo

Adicionar na Minha BVS

Imprimir

XML

PubMed Links

Buscar no Google